Literature DB >> 23060938

Diagnosis of ovarian cancers using thoracoscopy: Three case reports and review of the literature.

Makoto Nakao1, Tetsuya Oguri, Mikinori Miyazaki, Takehiro Uemura, Osamu Takakuwa, Eiji Kunii, Hirotsugu Ohkubo, Ken Maeno, Shigeki Sato.   

Abstract

Thoracoscopy is a useful method for diagnosing plural lesions. We diagnosed 3 cases of ovarian adenocarcinoma by thoracoscopy. All patients were middle-aged and elderly women. Initial examination revealed intrathoracic lesions including pleural effusion, but intraperitoneal lesions were unclear. In all cases, adequate samples of tumor cells obtained using thoracoscopy were used in the identification of tumor origin. Elevated serum levels of cancer antigen 125 (CA-125) and Krebs von den lungen-6 (KL-6) were observed in 2 of the 3 patients. Diagnoses of ovarian cancer were based on immunohistochemical examinations and clinical course. This report describes the diagnostic usefulness of thoracoscopy and serum KL-6 in cases of ovarian cancer with predominantly intrathoracic lesions.

Entities:  

Year:  2012        PMID: 23060938      PMCID: PMC3460298          DOI: 10.3892/etm.2012.541

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  13 in total

1.  Serum KL-6 levels in lung cancer patients with or without interstitial lung disease.

Authors:  Kunihiko Miyazaki; Koichi Kurishima; Katsunori Kagohashi; Mio Kawaguchi; Hiroichi Ishikawa; Hiroaki Satoh; Nobuyuki Hizawa
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 2.  Cancer of the ovary.

Authors:  Stephen A Cannistra
Journal:  N Engl J Med       Date:  2004-12-09       Impact factor: 91.245

3.  Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.

Authors:  Hiroshi Ohnishi; Akihito Yokoyama; Keiichi Kondo; Hironobu Hamada; Masahiro Abe; Kazutaka Nishimura; Kunio Hiwada; Nobuoki Kohno
Journal:  Am J Respir Crit Care Med       Date:  2002-02-01       Impact factor: 21.405

4.  Carcinomatous involvement of the pleura: an analysis of 96 patients.

Authors:  B Chernow; S A Sahn
Journal:  Am J Med       Date:  1977-11       Impact factor: 4.965

Review 5.  Medical thoracoscopy.

Authors:  Roberto F Casal; Georgie A Eapen; Rodolfo C Morice; Carlos A Jimenez
Journal:  Curr Opin Pulm Med       Date:  2009-07       Impact factor: 3.155

6.  Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma.

Authors:  N Kohno; M Akiyama; S Kyoizumi; M Hakoda; K Kobuke; M Yamakido
Journal:  Jpn J Clin Oncol       Date:  1988-09       Impact factor: 3.019

7.  Metastatic and histologic presentations in unknown primary cancer.

Authors:  J S Nystrom; J M Weiner; J Heffelfinger-Juttner; L E Irwin; J R Bateman; R M Wolf
Journal:  Semin Oncol       Date:  1977-03       Impact factor: 4.929

Review 8.  Diagnostic and therapeutic management of cancer of an unknown primary.

Authors:  N Pavlidis; E Briasoulis; J Hainsworth; F A Greco
Journal:  Eur J Cancer       Date:  2003-09       Impact factor: 9.162

9.  Investigation of pleural effusion: an evaluation of the new Olympus LTF semiflexible thoracofiberscope and comparison with Abram's needle biopsy.

Authors:  A N McLean; S R Bicknell; L G McAlpine; A J Peacock
Journal:  Chest       Date:  1998-07       Impact factor: 9.410

10.  A case of advanced ovarian cancer upstaged on the bases of pleural washing cytology.

Authors:  Yukari Kobayashi; Fumitoshi Terauchi; Hirotaka Nishi; Atsuya Fujitou; Hiroe Itou; Keiichi Isaka
Journal:  J Obstet Gynaecol Res       Date:  2009-06       Impact factor: 1.730

View more
  1 in total

1.  Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression.

Authors:  Sho Sato; Tomomi Kato; Kenji Abe; Tatsuya Hanaoka; Yuri Yano; Akira Kurosaki; Masanori Yasuda; Tetsuo Sekino; Keiichi Fujiwara; Kosei Hasegawa
Journal:  Oncol Lett       Date:  2017-05-25       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.